Clinical Trials
2
Active:0
Completed:0
Trial Phases
1 Phases
Phase 4:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 4
1 (100.0%)A Multicenter Real World Study of Kanglaite for Cancer Cachexia
- Conditions
- Cancer Cachexia
- Interventions
- Drug: Kanglaite Injection/Capsules
- First Posted Date
- 2018-08-15
- Last Posted Date
- 2018-08-21
- Lead Sponsor
- Zhejiang Kanglaite Pharmaceutical Co.Ltd
- Target Recruit Count
- 100000
- Registration Number
- NCT03631459
- Locations
- 🇨🇳
Peking University International Hospital, Beijing, Beijing, China
🇨🇳NanJing PLA 81 Hospital, Nanjing, Jiangsu, China
A Prospective, Randomized, Controlled, Multicenter Study of Kanglaite Injection for the Treatment of Cancer Cachexia
Phase 4
- Conditions
- Cancer Cachexia
- Interventions
- Drug: Kanglaite Injection
- First Posted Date
- 2015-09-17
- Last Posted Date
- 2017-02-15
- Lead Sponsor
- Zhejiang Kanglaite Pharmaceutical Co.Ltd
- Target Recruit Count
- 160
- Registration Number
- NCT02553187
- Locations
- 🇨🇳
Cancer Center, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
News
No news found